Statins for Prevention of Disease Progression and Hospitalization in Liver Cirrhosis

Inclusion Criteria: * Patients in the age of 18 to 80 years * Patients with liver cirrhosis, diagnosed by liver biopsy or ultrasound or CT scan of the liver and clinical biochemistry compatible with cirrhosis within the past 3 months. * In women, documented absence of pregnancy and unless in menopause commitment to use adequate contraception. * Clinically significant portal hypertension with a hepatic venous pressure gradient measured by liver vein catheterization \>10 mmHg. * Ability to read and understand project information in Danish and give written, informed consent. Exclusion Criteria: * People treated with statins within the last year. * People with liver cirrhosis, with a clinically verified infection (standard biochemistry, culture) within the last four weeks. * Pregnancy or lactation. * Hepatocellular carcinoma * HIV infection and treatment with protease inhibitors * People in whom the clinician and investigators may have reason to doubt compliance to trial medication * Clinical and biochemical signs of hepato-renal syndrome defined by current guidelines (EASL) within the last 14 days * A MELD score above 23, or Child-Pugh score higher than 13. * Hepatic encephalopathy grade 2 or higher